Ubs Group Ag Statera Biopharma, Inc. Transaction History

Ubs Group Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$0.08 - $0.23 $7,671 - $22,054	-95,888 Reduced 97.95%	2,011 $0
Q3 2022 Nov 10, 2022	BUY	$0.13 - $0.28 $11,614 - $25,016	89,346 Added 1044.62%	97,899 $13,000
Q2 2022 Aug 10, 2022	SELL	$0.21 - $0.38 $23,124 - $41,845	-110,119 Reduced 92.79%	8,553 $2,000
Q1 2022 May 16, 2022	BUY	$0.31 - $2.27 $36,788 - $269,385	118,672 New	118,672 $37,000
Q4 2021 Feb 14, 2022	SELL	$2.01 - $4.08 $39,134 - $79,437	-19,470 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.29 - $6.24 $44,586 - $121,492	19,470 New	19,470 $45,000

30K

Ticker STAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,295,700
Description
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.